Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1996-06-28
1999-01-05
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424426, 424468, A61K 910
Patent
active
058559159
ABSTRACT:
The present invention involves an aspirin/polyglycolide complex, its preparation and use. The complex provides a stable aspirin source, slowly releasing aspirin by dissociation or during polyglycolide degradation in vivo.
REFERENCES:
patent: 3422871 (1969-01-01), Schmitt et al.
patent: 4025613 (1977-05-01), Guy et al.
patent: 4166800 (1979-09-01), Fong
patent: 4308251 (1981-12-01), Dunn et al.
patent: 4375468 (1983-03-01), Dunn
patent: 4520009 (1985-05-01), Dunn
patent: 4994281 (1991-02-01), Muranishi et al.
patent: 5164188 (1992-11-01), Wong
patent: 5206030 (1993-04-01), Wheatley et al.
patent: 5206386 (1993-04-01), Narayanan et al.
patent: 5324519 (1994-06-01), Dunn
patent: 5447725 (1995-09-01), Damani et al.
patent: 5449382 (1995-09-01), Dayton
patent: 5458888 (1995-10-01), Chen
patent: 5487897 (1996-01-01), Polson et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5543156 (1996-08-01), Roorda et al.
patent: 5551954 (1996-09-01), Buscemi et al.
Yolles and Satori, "Erodible Matrices," In: Controlled Release Technologies, Chap. 1, pp. 2-6, 1980.
Anonymous, "Sustained Released Compositions," Res Discl, 259:567-570, 1985.
Asch et al., "Studies of a Controlled-Release Microcapsule Formulation of an LH-RH Agonist (D-Trp-6-LH-RH) in the Rhesus Monkey Menstrual Cycle," Int J Fertil, 30(2):19-26, 1985.
Bechgaard and Pedersen, "Rate of Drug Release from Intact and subdivided Controlled-Release Tablets," Pharmaceuticals, 86:325, Abstract No. 195155k, 1977.
Blume et al., "Bioavailability of Acetylsalicylic Acid Based Analgesics. Bioavailability of Two Immediate-Release ASA Tablet Formulations," Pharm Ztg Wiss, 6:59-64, 1993.
Blume et al., Eds., "Controlled/Modified Release Products. Recommendation in Support of EC-Guidelines," Stuttgart, Ger: Wissenschaftliche Verlagsgesellschaft mbH, 1991.
Brantmark et al., "Bioavailability of Acetylsalicylic Acid and salicyclic Acid from Rapid-and slow-Release Formulations and in Combination with Dipyridamol," Eur J Clin Pharmacol, 22:309-214, 1982.
Casadio et al., "Acetylsalicylic Acid-Containing Drugs with Sustained Release," Pharmaceuticals, 77:303, Abstract No. 9593t, 1972.
Chapman et al., "Sustained Release of Drugs in Certain Drug-Resin Complexes as Judged by Urinary Excretion Rates," Can Med Assoc J, 81:470-476, 1959.
Charles, "Sustained-Release Aspirin," Chem. Abstr, 100:362, Abstract No. 126906b, 1984.
Charman et al., "Biopharmaceutical Characterisation of a Low-dose (75 mg) Controlled-Release Aspirin Formulation," Br. J. Clin Pharmacol, 36:470-473, 1993.
Chen, "Controlled-Release Tablets Comprising Coated cores and PEG Coatings," Chem. Abstr, 123:712, 1995.
Chick, "Programmed-Release Compositions Containing Acetylsalicyclic Acid and Dihydroergotamine," Pharmaceuticals, 101:313, Abstract No. 235613v, 1984.
Chick, "Programmed-Release Pharmaceuticals Containing Acetylsalicylic Acid," Chem Abstr, 101:356, Abstract No. 157704j, 1984.
Choudhury and Mitra, "Kinetics of Aspirin Hydrolysis and stabilization in the Presence of 2-Hydroxypropyl-.beta.-Cyclodextin," Pharm. Res., 10(1):156-159, 1993.
Chowdary and Rao, "Studies on a New technique of Microencapsulation: Part V. Microencapsulation of Aspirin by Ethylcellulose," Indian Drugs, 22(9):479-481, 1985.
Deasy and Murtagh, "Controlled Release Antiplatelet Product Containing Dipyridamole and Aspirin," Chem Abstr, 119:556, Abstract No. 233957h, 1993.
Dong and Rogers, "Acacia-Gelatin Microencapsulated Liposomes: Preparation, Stability, and Release of Acetylsalicylic Acid," Pharm Res, 10(1):141-146, 1993.
Dunn and Lampard, "Pharmaceutical Composition with a Prolonged Effect," Chem Abstr, 95:381-381, Abstract No. 225675k, 1981.
Froemming and Topaloglu, "Influence of Ethanol on the In Vitro and In Vivo Drug Release from Some Sustained Release Tablets," Chem Abstr, Abstract No. 84:99089e, 1976.
Fromming and Topaloglu, "Beeinflussung der In-vitro-und In-vivo-Pharmakonfreisetzung Aus Einigen Peroralen Depotformen unter Athanolbelastung," Arzneim-Forsch, 25:1958-1964, 1975 (See Ref C19 for English Abstract).
Fujimoto, "Aspirin-Dextrin Inclusion Compounds," Chem Abstr, 90:286, Abstract No. 76581u, 1979.
Gaudy et al., "Controlled-Release Acetylsalicylic Acid Hydrophilic Matrix Tablets," Congr. Int. Technol. Pharm 6th, 3:365-372, 1992.
Gilding and Reed, "Biodegradable Polymers for Use in Surgery--Polyglycolic/Poly(Actic Acid) Homo-and Copolymers: 1," Polymer, 20:1459-1464, 1979.
Ginde and Gupta, "In Vitro Chemical Degradation of Poly(Glycolic Acid) Pellets and Fibers," J of App Poly Sci, 33:2411-2429, 1987.
Habib et al., "Effect of Certain Additives on the Diffusion Characteristics of Aspirin, Salicylamide and Phenacetin Through A Cellophane Membrane. II. Effect of Aliphatic Acids and Polyethylene Glycol.," Chem Abstr, Abstract No. 104:174526g, 1986.
Hariharan and Pinkus, "Useful NMR Solvent Mixture for Polyesters: Trifluoroacetic Acid-d/Chloroform-d," Polymer Bulletin, 30:91-95, 1993.
Hosoi et al., "Use of Porous Particles for Preparation of Capsules Containing Aspirin and Drug Release properties," Chem Abstr, Abstract No. 103:166045p, 1985.
Hutchinson and Furr, "Biodegradable Polymers for the sustained Release of Peptides," Biochemical Society Trans, 13:520-523, 1985.
Ikada and Gen, "Sustained-Release Pharmaceuticals Containing Lactic Acid Polymers," Chem Abstr, 104:384, Abstract No. 39744m, 1986.
Ishii et al., "Sustained-Release Preparations for Bone Implants," Pharmaceuticals, 123:671, Abstract No. 179584b, 1995.
Karahalios et al., "Comparative Bioavailability of Sustained-Release and Uncoated Aspiring Tablets," Am J Hosp Pharm., 38;1754-1756, 1981.
Kawashima et al., "Preparation of a Prolonged Release Tablet of Aspirin with Chitosan," Chem. Pharm. Bull, 33(5)2107-2113, 1985.
Khan and Alam, "The In-Vitro Study of Sustained Release Aspirin Tablet with Polyethylene Resin as Insoluble Matrix," Pakistan J. Sci. Ind. Res., 23(6):283-286, 1980.
Kitajima et al., "Encapsulation with Polymeric Materials," Plastics Fabrication and Uses, 73:43, Abstract No. 78221z, 1970.
Kydonieus, Ed., "Treatise on Controlled Drug Delivery," New York: Marcel Dekker, Inc., 1991.
Li et al, "Copolymer of 1-(acetylsalicyloyloxy)ethyl Methacrylate and Its Hydrolysis," Chem Abstrs, Abstract No. 102:190971n, 1985.
Li et al., "Sucralfate as a Bioadhesive Gastric Intestinal Retention System: Preliminary Evaluation," Drug Development and Industrial Pharmacy, 19(19) 2519-2537, 1993.
Linhardt, "Biodegradable Polymers for controlled Release of Drugs," Controlled Release of Drugs, Rosoff, Ed., New York: VCH Publishers, Chapter 2, p. 82, 1989.
Lobeck and Spigiel, "Bioavailability of Sustained-Release Aspirin Preparations," Clinical Pharmacy,5:236-238, 1986.
Molloy et al., "Method for Production of Solid Pharmaceutical Dosage Forms," Chem Abstr, 118:352, Abstract No. 27464w, 1993.
Murakami et al., "Manufacture of Sustained-Release Pharmaceutical Microspheres," Pharmaceuticals, 118:459, Abstract No. 154585k, 1993.
Naplatanova et al., "Depo-acetysal Tablets," Chem Abstrs, Abstract No. 76:158288d, 1972.
Nikolayev and Gebre-Mariam, "Preparation and Bioavailability Studies of Aspirin Ethyl Cellulose Microcapsules," Indian Drugs, 30(8):392-397, 1993.
Pinkus and Subramanyam, "New High-Yield, One-Step Synthesis of Polyglycolide from Haloacetic Acids," J of Polymer Science: Polymer Chemistry Edition, 22:1131-1140, 1984.
Plaizier-Vercammen and van den Bossche, "Evaluation of the Tabletting Properties of a New Exipient for Direct Compression," Pharm Ind, 54:973-977, 1992.
Ramstack et al., "Preparation of Biodegradable Microparticles Containing a Biologically active Agent," Chem Abstr, 123:664, Abstract No. 179481r, 1995.
Rehders et al., Plasma Salicylate Levels and Platelet Function After Acute and Chronic Administration of Slow-Release Acetylsalicylic Acid (Monobeltin), Eur J Clin Pharmacol, 27:638-687, 1985.
Rettenmaier, "Coated Cellulose Particles for Direct Dry Drug Tabetling," Pharmaceuticals, 118:499, Abstract No. 132173y, 1993.
Roberts et al., "Inhibition of Platelet Function by a Controlled Release Acetylsalicylic Acid Formulation-Single and Chronic Do
Baylor University
Webman Edward J.
LandOfFree
Tablets or biologically acceptable implants for long-term antiin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tablets or biologically acceptable implants for long-term antiin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tablets or biologically acceptable implants for long-term antiin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-859880